Rhenman & Partners strengthens its investment team with a biopharma analyst


Stockholm, December 20, 2022 /PRNewswire/ — Rhenman & Partners Hires Amennai Beyeen as Biopharmaceutical Analyst. Amennai will have a particular focus on biopharmaceutical companies and the development of new drugs and therapeutics. He will work closely with all colleagues on his five-person investment team at Rhenman & Partners. Stockholm office. Most recently, Amennai came from Novartis and is working on developing and launching new drugs. Amennai previously holds a PhD in neuroimmunology. Karolinska Institute of Stockholm in Sweden.

“We are very pleased to welcome Amennai to Rhenman & Partners. Amennai’s strong background and competence in the world of research and the pharmaceutical company we have been able to follow closely from idea to final product. His experience at , makes him a very good member of our investment team.” henrik lenmannCo-founder and CIO of Rhenman & Partners.

“My start at Rhenman & Partners is very exciting. I was very impressed with the team’s deep knowledge of the healthcare sector and the fund’s versatile investment process. I am looking forward to joining, and I was able to contribute with this talented team and my experience in the life sciences,” said Amennai Beyeen.

Amennai joins Rhenman & Partners. April 2023.

For more information, please contact:

Karin Yelten | Communications Manager, Rhenman & Partners Asset Management
Phone: +46 (0)706521908 | Email: karin@rhepa.com

Rhenman & Partners Asset Management

Rhenman & Partners Asset Management AB (Rhepa) was founded in 2008, StockholmAn asset manager focused on the healthcare sector. Rhepa is responsible for a portfolio of sector funds registered with. Luxembourg: Rhenman Healthcare Equity L/S (RHE L/S). The fund is managed by FundRock Management Company SA, which has entrusted Rhepa with the management of the fund’s portfolio. Rhepa’s experienced investment team is supported by a scientific advisory board of medical experts with a global network of researchers and experts.

You can download the following files:

Sision

Sision

View original content: https://www.prnewswire.co.uk/news-releases/rhenman–partners-strengthens-its-investment-team-with-a-biopharma-analyst-301706938.html



Source link

Leave a Reply

%d bloggers like this: